349 related articles for article (PubMed ID: 28570043)
21. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation.
Zheng C; Qiu L; Yao X; Zhu K
Int J Pharm; 2009 May; 373(1-2):133-40. PubMed ID: 19429298
[TBL] [Abstract][Full Text] [Related]
22. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
24. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
[TBL] [Abstract][Full Text] [Related]
25. Zwitterionic Phosphorylcholine-TPE Conjugate for pH-Responsive Drug Delivery and AIE Active Imaging.
Chen Y; Han H; Tong H; Chen T; Wang H; Ji J; Jin Q
ACS Appl Mater Interfaces; 2016 Aug; 8(33):21185-92. PubMed ID: 27482632
[TBL] [Abstract][Full Text] [Related]
26. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.
Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z
Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667
[TBL] [Abstract][Full Text] [Related]
27. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
28. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
29. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
[TBL] [Abstract][Full Text] [Related]
30. Construction of Small-Sized, Robust, and Reduction-Responsive Polypeptide Micelles for High Loading and Targeted Delivery of Chemotherapeutics.
Xue S; Gu X; Zhang J; Sun H; Deng C; Zhong Z
Biomacromolecules; 2018 Aug; 19(8):3586-3593. PubMed ID: 30025206
[TBL] [Abstract][Full Text] [Related]
31. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
32. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
33. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
[TBL] [Abstract][Full Text] [Related]
34. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
35. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
[TBL] [Abstract][Full Text] [Related]
36. Redox and pH Dual-Responsive Polymeric Micelles with Aggregation-Induced Emission Feature for Cellular Imaging and Chemotherapy.
Zhuang W; Xu Y; Li G; Hu J; Ma B; Yu T; Su X; Wang Y
ACS Appl Mater Interfaces; 2018 Jun; 10(22):18489-18498. PubMed ID: 29737837
[TBL] [Abstract][Full Text] [Related]
37. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.
Pawar S; Mahajan K; Vavia P
AAPS PharmSciTech; 2017 Nov; 18(8):3021-3033. PubMed ID: 28497240
[TBL] [Abstract][Full Text] [Related]
39. Folic acid grafted and tertiary amino based pH-responsive pentablock polymeric micelles for targeting anticancer drug delivery.
Chen Q; Zheng J; Yuan X; Wang J; Zhang L
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():1-9. PubMed ID: 29025636
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y
Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]